NDC 50242-175

EVRYSDI

Risdiplam

EVRYSDI is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech Inc.. The primary component is Risdiplam.

Product ID50242-175_1316f231-2d4d-4624-a8b7-b05ac2b9456d
NDC50242-175
Product TypeHuman Prescription Drug
Proprietary NameEVRYSDI
Generic NameRisdiplam
Dosage FormPowder, For Solution
Route of AdministrationORAL
Marketing Start Date2020-08-07
Marketing CategoryNDA / NDA
Application NumberNDA213535
Labeler NameGenentech Inc.
Substance NameRISDIPLAM
Active Ingredient Strength1 mg/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 50242-175-07

1 BOTTLE, GLASS in 1 CARTON (50242-175-07) > 80 mL in 1 BOTTLE, GLASS
Marketing Start Date2020-08-07
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [EVRYSDI]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EVRYSDI
EVRYSDI
90622036 not registered Live/Pending
Genentech, Inc.
2021-04-02
EVRYSDI
EVRYSDI
88769281 not registered Live/Pending
Genentech, Inc.
2020-01-22
EVRYSDI
EVRYSDI
88350381 not registered Live/Pending
Genentech, Inc.
2019-03-21
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.